Cephalon’s Deal to Acquire Arana Therapeutics

By Taskin Ahmed

Pharma Deals Review: Vol 2009 Issue 4 (Table of Contents)

Published: 13 Apr-2009

DOI: 10.3833/pdr.v2009.i4.1095     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Cephalon launched a takeover offer for Australian biotechnology company, Arana Therapeutics, which specialises in developing the next generation of antibody-based drugs to treat inflammatory conditions and cancer...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details